Use Case

Digital therapeutics

Digital‑therapeutic (DTx) products are evolving from reminder apps into evidence‑driven platforms that combine behavior change with medication management and device data. The literature shows mixed adherence gains from digital tools—highlighting the need for deeper analytics and individualized dosing logic.

Evidence snapshot

Narrative and systematic reviews report variable effects of digital interventions on medication adherence—often limited when tools are simplistic (e.g., reminders only). (Moon 2025)
To unlock value, DTx needs mechanisms that integrate multi‑modal data (wearables, PROs) with decision logic rather than static tracking.

What OptimDosing enables

SDK / API integration

Drop‑in dosing intelligence and trigger analytics for web/mobile stacks.

Personalized titration

Use real‑time physiology + behavior signals to recommend safer, effective dose adjustments (where permitted).

Outcomes intelligence

Attribute symptom changes and adherence patterns to specific dose and lifestyle factors.

References

Moon Z, et al. Digital interventions in medication adherence: current evidence and challenges. Narrative review, 2025.